Search Results for "vaccine, pneumococcal"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vaccine, pneumococcal. Results 21 to 26 of 26 total matches.
Expanded Table: Some Vaccines for Adults (online only)
The Medical Letter on Drugs and Therapeutics • Oct 17, 2022 (Issue 1661)
during or after
1980 without evidence of
immunity (documentation of
vaccination, laboratory evidence ...
Belimumab (Benlysta) for Systemic Lupus Erythematosus
The Medical Letter on Drugs and Therapeutics • Jun 13, 2011 (Issue 1366)
-specific
inhibitor, on functional antibodies to pneumococcal, tetanus,
and influenza vaccines. Arthritis ...
Belimumab (Benlysta – Human Genome Sciences/GlaxoSmithKline) has been approved by the FDA for
treatment of adults with active, autoantibody-positive, systemic lupus erythematosus (SLE). It is the first biologic
agent approved for SLE and the first drug of any kind to be approved for this disease in >50 years.
Drugs for COPD
The Medical Letter on Drugs and Therapeutics • Sep 02, 2024 (Issue 1710)
;
pharmacotherapy can be helpful.
▶ Influenza and pneumococcal vaccines are recommended to
decrease the incidence ...
The main goals of treatment of chronic obstructive
pulmonary disease (COPD) are to relieve symptoms,
reduce the frequency and severity of exacerbations,
prevent disease progression, and reduce mortality.
GOLD (Global Initiative for Chronic Obstructive Lung
Disease) guidelines for treatment of COPD were
updated recently. Treatment of acute exacerbations
is not discussed here. Drugs available for treatment
of COPD are listed in Tables 1 and 3.
Med Lett Drugs Ther. 2024 Sep 2;66(1710):137-44 doi:10.58347/tml.2024.1710a | Show Introduction Hide Introduction
Antibacterial Drugs for Community-Acquired Pneumonia
The Medical Letter on Drugs and Therapeutics • Jan 25, 2021 (Issue 1616)
common causative bacterial
pathogens. In the US, pneumococcal vaccination has
substantially reduced ...
Treatment of community-acquired pneumonia (CAP)
is usually empiric, with selected antibiotic regimens
directed against some of the most common causative
pathogens. Recommended empiric regimens are
listed in Table 2; recommended antibiotic dosages for
treatment of CAP are listed in Tables 3 and 4. Joint
guidelines for treatment of CAP by the American
Thoracic Society and the Infectious Diseases Society of
America (ATS/IDSA) were updated in 2019.
Drugs for Common Bacterial Infections in Adults
The Medical Letter on Drugs and Therapeutics • Oct 23, 2017 (Issue 1532)
monotherapy for empiric treatment of CAP could result
in treatment failure in patients with pneumococcal ...
Bacterial infections in adults are generally treated
empirically, with the antibiotic covering most, but not
all, of the potential causative pathogens. For some
infections, culture and sensitivity testing can guide
treatment, allowing for use of narrower-spectrum
antibiotics. The recommended dosages and durations
of antibiotic treatment for common respiratory, skin, and
urinary tract infections are listed in Tables 1-3. Infectious
disease experts now recommend shorter treatment
durations for many infections to reduce the development
of antimicrobial resistance and minimize adverse...
Drugs for Bacterial Infections
Treatment Guidelines from The Medical Letter • Jul 01, 2013 (Issue 131)
have
anaerobic activity, are reasonable alternatives.
In treating pneumococcal pneumonia due to strains ...
The text that follows reviews some common bacterial
infections and their empiric treatment pending the
results of culture and susceptibility testing. The recommendations
made here are based on the results of
susceptibility studies, clinical trials, and the opinions
of Medical Letter reviewers. Tables 1 and 2 list the usual
dosages of antibacterial drugs.